Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
Phase 1
Recruiting
- Conditions
- Squamous Cell Carcinoma of Head and NeckEndometrial CancerHR+/HER2-negative Breast CancerBladder Cancer
- Interventions
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Totus Medicines
- Target Recruit Count
- 241
- Registration Number
- NCT05683418
- Locations
- 🇺🇸
University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
News
No news found